Project Details
| Short title | A Phase 1 Dose Escalation Study to Investigate the Safety, Immunoregulatory Activity, Pharmacokinetics, and Preliminary Antitumour Activity of Anti-Programmed-Death-1 (PD-1) Antibody (BMS-936558) in Advanced Hepatocellular Carcinoma in... |
|---|---|
| Status | Finished |
| Effective start/end date | 4/09/15 → 31/12/21 |
Funding
- Uhb Nhs Trust